Method AI
Category: AI in Healthcare
AI-powered surgical navigation platform providing real-time visualization and precision in robotic oncology surgeries using continuous 3D ultrasound imaging. Method AI was founded in 2021. The company is led by Marco Monteiro. Based in Boston, MA, USA. Team size: 11-50. Total funding raised: $20M. Latest round: Series A. Key investors include Not publicly disclosed.
- Founded
- 2021
- Headquarters
- Boston, MA, USA
- Team size
- 11-50
- Total funding
- $20M
Value proposition
Enables surgeons to visualize critical subsurface anatomy beyond standard cameras, improving accuracy and outcomes in oncology surgeries.
Products and solutions
AI surgical navigation platform leveraging continuous 3D ultrasound and machine learning for real-time guidance.
Unique value
Continuous, real-time 3D ultrasound imaging integrated into surgical workflows to visualize deep tissue structures not visible to regular surgical cameras.
Target customer
Surgical oncologists and hospitals using robotic surgery platforms.
Industries served
Healthcare, Medical Technology, Surgical Oncology
Technology advantage
Proprietary machine learning algorithms analyze live 3D ultrasound data to create real-time maps of important subsurface features, enhancing surgical precision.
How they differentiate
Method AI offers continuous 3D ultrasound imaging with AI-driven real-time navigation to visualize deep anatomy during oncology surgeries, setting it apart from competitors relying on standard imaging.
Main competitors
Medivis, Virtual Incision, Medtronic
Key partnerships
Cleveland Clinic
Notable customers
Cleveland Clinic
Major milestones
Founded in 2021, Spin-out from Cleveland Clinic, Raised $20M in Series A
Growth metrics
Early-stage private company; specific growth metrics not publicly available.
Market positioning
Positioned as a specialized innovator enhancing robotic oncology surgery with AI image guidance, backed by a Cleveland Clinic origin.
Geographic focus
United States, headquartered in Boston, MA.
Patents and IP
Not publicly disclosed.
About Marco Monteiro
Co-Founder & CEO at Method AI. Previously Product Manager and Software Engineer at Meta. Alumnus of Y Combinator S17 batch.
Official website: https://www.methodsurgical.ai/